Global Impact of 2022

At MAP International, we believe that everyone deserves access to quality healthcare, no matter where they live. That’s why we’re committed to providing life-changing patient treatments to people in need around the world.

Our efforts have enabled us to provide critical medicines and health supplies to millions of people in 86 countries around the world. We’re also pleased to report that we increased our medicine delivery by $119 million from the previous year, totaling $745,372,921. Additionally, we provided $37,549,164 in disaster relief – a $24 million increase from 2021. Our mission is simple yet impactful: to provide essential medicines and health supplies to those in need so they can live life to the fullest.

In the fiscal year 2022 alone, we delivered over 16 million prenatal vitamins to 49 countries to support maternal and fetal health. We also provided over 119,000 oral rehydration salts, totaling nearly 3 million sachets, to 45 countries to help prevent dehydration. Additionally, we administered over 1.8 million deworming medications to patients in 15 countries and provided over 800,000 antibiotics to individuals in 57 countries. Through our Bringing Children Health (BCH) Program, we were able to reach over 324,000 children – an increase of over 243,000 from the previous year. By targeting our efforts where they’re needed most, we can make a real impact and improve the health and wellbeing of children around the world.

Thanks to our dedicated team and generous supporters, we’re able to make a real difference in the lives of those who need it most. Join us in our mission to create a healthier, more equitable world today.

Read our Annual Report

Providing Hope Close to Home

The Problem

More than 65 million Americans – nearly one in five – are uninsured or underinsured, leaving them vulnerable to one of the most pressing health inequity issues in the country: lack of access to essential medicine.

Patients living in poverty or working low-wage jobs often face impossible choices between food, rent, and life-sustaining prescriptions.

The consequences are staggering, 21% of adults report skipping or rationing medications due to cost (Kaiser Family Foundation study, 2023). Medication nonadherence contributes to an estimated 125,000 deaths and 10% of hospitalizations in the U.S. each year (Annals of Internal Medicine, 2018).

Our Solution

MAP USA is a bold solution to the nation’s medication access crisis. The program transforms surplus FDA approved medicine, health supplies and medical devices, along with purchased medicine into life-changing therapies for low-income, uninsured, and underinsured individuals. MAP is seeking a one-time philanthropic investment of $448,000 to expand MAP USA on a national scale. This is a moment of opportunity.

Impact Goals

The startup investment requested in this proposal will fund the essential infrastructure, staffing, and systems required to launch MAP USA and position the program for national scale.

Over the 12-18 month startup phase, MAP USA will:

  1. Serve at least 170,000 thirty-day prescriptions to uninsured and underinsured patients through partner clinics and pharmacies by the end of Year 1.
  2. Engage and onboard 10-15 new beta clinic partners and transition all 130+ existing partners to updated agreements, compliance protocols, and the new ordering platform by Month 18.
  3. Establish a core formulary of 30+ essential medicines and secure a minimum of three new manufacturer or distributor sourcing agreements by Month 12.
  4. Achieve a 4:1 return on philanthropic investment in medicine value delivered to partner sites by the end of the startup period.
  5. Maintain a 95% partner retention rate among clinics and pharmacies enrolled in MAP USA during the startup phase.

These startup deliverables will lay the groundwork for MAP USA to expand medicine access to hundreds of thousands more patients in the years ahead.

By Year 5, MAP USA anticipates:

  1. Serving 500,000 patients annually through 1,000+ partner clinics and pharmacies.
  2. Distributing $200 million in medicine-value annually, with emphasis on chronic disease and maternal health.
  3. Improving medication adherence, lowering avoidable ER visits, and increasing clinic capacity through consistent formulary access.

Currently serving 130 partner clinics in 9 states

Program Growth

Planned Investment

To successfully launch MAP USA, MAP is seeking a one-time startup investment to build the core infrastructure required for national expansion. This includes establishing robust IT systems, ensuring legal and regulatory compliance, onboarding dedicated startup staff, and configuring logistics and distribution infrastructure.

MAP’s strong financial controls, experience managing complex in-kind logistics, and proven ability to steward foundation funding ensure that this investment will be deployed with efficiency, transparency, and accountability. MAP USA is ready to scale in alignment with foundation priorities and deliver measurable, lasting impact to communities most in need.

The breakdown below reflects the full scope of startup needs outlined in MAP’s internal growth plan.

IT Infrastructure & System
$100,000
Development and set up of a new inventory and partner management platform, including a rapid design contractor.

Legal, Licensing & Accreditation
$82,500
Legal support to revise partner contracts and medicine donor agreements, and to obtain required accreditations and licenses.

Staffing & Operational Expansion
$150,000
Initial staffing to support clinic onboarding, operations, and implementation of new systems.

Logistics & Facility Setup
$66,000
Configuration of fulfillment, storage, and distribution infrastructure to support expansion.

Contingency & Administrative Costs
$50,000
Flexible funding to address emerging startup needs and ensure timely execution.

Total
$448,500
Reflects variability in IT development, legal contracting, and accreditation requirements.